Defunct Company
Total Trials
9
As Lead Sponsor
7
As Collaborator
2
Total Enrollment
2,045
NCT01184378
Tolerance and Digestibility of a New Formula in Healthy Infants
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 30, 2008
Completion: Jan 31, 2011
NCT01611649
Effect of a Mix of Dairy Lipids and Plant Oils in Infant Formula on Omega-3 Fatty Acid in Red Blood Cells
Start: Mar 31, 2012
Completion: Not specified
NCT02117609
Effect of a New High-protein Oral Supplement on Functional Parameters in Patients in Nursing Homes
Start: May 31, 2012
NCT01909661
Tolerance of Infants With Cow's Milk Protein Allergy to Extensively Hydrolyzed Rice Protein or Casein Infant Formulas
Start: Mar 31, 2013
Completion: Aug 31, 2014
NCT01946841
Specific Enteral Nutrition in Malnourished, Dialysis Patients With Chronic Kidney Disease. Efficacy, Safety, Quality of Life
Start: Aug 31, 2013
Completion: Jul 31, 2014
NCT03941392
Nutritional Study in Spanish Pediatric Population
Phase: N/A
Role: Collaborator
Start: Oct 2, 2018
Completion: Aug 31, 2019
NCT05471206
Evaluation of Gastrointestinal pH and Motility After the Consumption of Milk
Start: Nov 24, 2022
Completion: Feb 15, 2024
NCT06273371
Tolerance and Growth Outcomes in Children Diagnosed With Cow's Milk Protein Allergy and Prescribed an Extensively Hydrolyzed Casein Formula (Damira 2000©) in Spain
Start: Dec 12, 2023
Completion: Dec 21, 2023
NCT06358716
Glycaemic Index Determination in Oral Nutrition Supplements
Start: Apr 15, 2024
Completion: Aug 15, 2024